Purinergic receptors as future targets for treatment of functional Gl disorders
- A Strategy for Management of the Irritable Bowel. Thompson, W. Grant // American Journal of Gastroenterology;Feb1986, Vol. 81 Issue 2, p95
Presents research which discussed a medical technique for management of the irritable bowel syndrome. Efficiency of sigmoidoscopy in detecting the disease; Information on drugs used in the treatment of the syndrome; Importance of harmonious physician-patient relationship to the recovery of...
- Hypothesis Driven Research and Molecular Mechanisms in Functional Dyspepsia: The Beginning of a Beautiful Friendship in Research and Practice? Holtmann, Gerald; Talley, Nicholas J. // American Journal of Gastroenterology;Mar2006, Vol. 101 Issue 3, p593
There is accumulating evidence of a genetic predisposition in at least a subset of patients with functional GI symptoms. Hence, hunting for genes in irritable bowel syndrome and functional dyspepsia has become fashionable of late. Unfortunately, as in other fields, replication of gene...
- Isogel. // Royal Society of Medicine: Medicines;2002, p309
The article presents information on isogel, a proprietary, non-prescription preparation of the (bulking-agent) laxative ispaghula husk. It can be used to treat a number of gastrointestinal disorders, including irritable bowel syndrome, and is available as granules.
- Prevalence and risk factors for abdominal bloating and visible distention: a population-based study. Jiang, X.; Locke III, G. H.; Choung, A. S.; Zinsmeister, A. A.; Schleck, C. D.; Talley, N. J. // Gut;Jun2008, Vol. 57 Issue 6, p756
Background: Abdominal bloating and visible distention are common yet poorly understood symptoms. Epidemiological data distinguishing visible distention from bloating are not available. We aimed to evaluate the prevalence and potential risk factors for abdominal bloating and visible distention...
- Î±2Î´ ligand: a new, smart pill for visceral pain in patients with hypersensitive irritable bowel syndrome? Camilleri, Michael // Gut;Oct2007, Vol. 56 Issue 10, p1337
The article presents the author's perspective on the concept of the heteromultimeric voltage-sensitive calcium channel. This has been involved in the function of excitable tissues including sensory nerves. The author stated that pregabalin has been shown to be effective in several animal models...
- Irritable bowel syndrome? Lipman, Marvin M. // Consumer Reports on Health;Jan2003, Vol. 15 Issue 1, p11
Discusses key issues concerning irritable bowel syndrome (IBS) in the U.S. Diagnosis; Disorders that mimic IBS; Treatment of IBS symptoms.
- Treatment of Irritable Bowel Syndrome. Hadley, Susan K.; Gaarder, Stephen M. // American Family Physician;12/15/2005, Vol. 72 Issue 12, p2501
Irritable bowel syndrome affects 10 to 15 percent of the U.S. population to some degree. This condition is defined as abdominal pain and discomfort with altered bowel habits in the absence of any other mechanical, inflammatory, or biochemical explanation for these symptoms. Irritable bowel...
- THE IRRITABLE COLON--THE GREAT IMPERSONATOR. Heffernon, Elmer W. // American Journal of Gastroenterology;May1965, Vol. 43 Issue 5, p468
Presents information on the irritable colon. Pathology of the disease; Diagnosis; Treatment.
- Irritable Bowel Syndrome. // Ebony;Jul2005, Vol. 60 Issue 9, p92
Presents information on the occurrence of irritable bowel syndrome (IBS) in African Americans. Symptoms of the disorder; Treatments for the disorder; Causes of IBS.